Latest Breaking News On - கேடீ கல்லாகர் - Page 4 : comparemela.com
Nephraegis Therapeutics Launches with Seed Financing to Develop Small Molecules to Prevent and Treat Acute Kidney Injury (AKI)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Xontogeny Announces Launch of Several New Early-Stage Portfolio Companies
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Dr. Jacque Sokolov Joins PAVmed Subsidiary Lucid Diagnostics’ Board of Directors
PAVmed Inc.April 29, 2021 GMT
NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that its major subsidiary Lucid Diagnostics Inc. (“Lucid” or the “Company”) has appointed nationally recognized healthcare executive Jacque J. Sokolov to its Board of Directors (the “Board”). Dr. Sokolov will help establish and serve as the inaugural Chair of the Board’s new Compliance & Quality Committee. He will also serve on Lucid’s Audit and Compensation Committees.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
AC Immune Reports First Quarter 2021 Financial Results and Provides Corporate Update
AC Immune SAApril 28, 2021 GMT
Reported potent interim immunogenicity results for anti-pTau Alzheimer’s vaccine in ongoing Phase 1b/2a study, which support further development into Phase 2/3
Initiated first-in-human clinical study for next-generation alpha-synuclein PET diagnostic with results expected in Q3 2021
Advanced multiple candidates targeting the NLRP3 inflammasome pathway for CNS and non-CNS indications
Strong financial position of CHF 216.1 million in cash ensures the Company is fully financed through at least Q1 2024
LAUSANNE, Switzerland, April 28, 2021 (GLOBE NEWSWIRE) AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today reported its financial results for the quarter ended March 31, 2021. The Co
RESIDENTS across the city have had their say after the Glasgow Times launched our Save Our Venues campaign. From mums and toddlers to older adults, Glaswegians of all ages are set to be affected by the possible closure of many of the city’s venues. West End locals have hit out at Glasgow Life after they announced the closure of Whiteinch Library. Katie Gallagher and her daughters have used the library in the past but her younger daughter has missed out on a lot due to lockdown. She said:”When my oldest was born, we used to go to bounce and rhyme in there and things like that.
vimarsana © 2020. All Rights Reserved.